Bristol-Myers Squibb Co (BUE:BMY) Cyclically Adjusted FCF per Share: ARS2,857.89 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:BMY Bristol-Myers Squibb Co BUE:BMY
55 GF Score
Price ARS31,820.00
GF Value ARS28,117.77
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share?

Bristol-Myers Squibb Co BUE:BMY 55 Cyclically Adjusted FCF per Share is ARS2,857.89 as of Mar. 2026. GuruFocus rates BUE:BMY with a GF Score™ of 55/100 and a GF Value™ of ARS28,117.77 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ARS517.084. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ARS2,857.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average Cyclically Adjusted FCF Growth Rate was 14.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 13.10% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bristol-Myers Squibb Co was 14.70% per year. The lowest was -1.70% per year. And the median was 7.50% per year.

As of today (2026-07-23), Bristol-Myers Squibb Co's current stock price is ARS31820.00. Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ARS2,857.89. Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF of today is 11.13.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.22. The lowest was 7.74. And the median was 19.59.


Bristol-Myers Squibb Co  (BUE:BMY) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=31820.00/2857.89
=11.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bristol-Myers Squibb Co was 40.22. The lowest was 7.74. And the median was 19.59.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Related Terms


Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 238.77 433.57 1,407.99 1,971.83 2,877.22

Bristol-Myers Squibb Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,245.20 2,161.82 2,893.78 2,877.22 2,857.89

BUE:BMY vs PFE, GILD, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF falls into.


BUE:BMY
55GF Score
Bristol-Myers Squibb Co BUE:BMY
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=517.084/330.2130*330.2130
=517.084

Current CPI (Mar. 2026) = 330.2130.

Bristol-Myers Squibb Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 1.482 241.018 2.030
201609 9.444 241.428 12.917
201612 10.097 241.432 13.810
201703 5.259 243.801 7.123
201706 13.350 244.955 17.997
201709 15.457 246.819 20.680
201712 10.030 246.524 13.435
201803 11.500 249.554 15.217
201806 13.095 251.989 17.160
201809 23.730 252.439 31.041
201812 75.203 251.233 98.845
201903 28.321 254.202 36.789
201906 51.639 256.143 66.572
201909 80.980 256.759 104.147
201912 59.465 256.974 76.413
202003 103.110 258.115 131.911
202006 131.959 257.797 169.027
202009 68.534 260.280 86.948
202012 111.012 260.474 140.734
202103 145.202 264.877 181.018
202106 119.885 271.696 145.705
202109 217.793 274.310 262.178
202112 169.923 278.802 201.257
202203 176.588 287.504 202.820
202206 111.371 296.311 124.113
202209 222.527 296.808 247.572
202212 233.857 296.797 260.187
202303 251.682 301.836 275.344
202306 185.880 305.109 201.174
202309 747.543 307.789 802.005
202312 696.430 306.746 749.709
202403 1,061.975 312.332 1,122.773
202406 910.947 314.175 957.449
202409 2,464.935 315.301 2,581.513
202412 2,020.498 315.605 2,114.018
202503 885.229 319.799 914.056
202506 2,071.541 322.561 2,120.683
202509 3,990.119 324.800 4,056.617
202512 1,141.829 324.054 1,163.531
202603 517.084 330.213 517.084

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ARS2,857.89 mean?
Bristol-Myers Squibb Co (BUE:BMY) has a Cyclically Adjusted FCF per Share of ARS2,857.89 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share too high?
Bristol-Myers Squibb Co's current Cyclically Adjusted FCF per Share is ARS2,857.89. Overall, Bristol-Myers Squibb Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share compare to PFE and GILD?
Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share of ARS2,857.89 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current Cyclically Adjusted FCF per Share is ARS2,857.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BUE:BMY) is currently considered Modestly Overvalued. The stock's GF Value™ is ARS28,117.77, compared to a current price of ARS31,820.00 — trading 13.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ARS2,857.89. Bristol-Myers Squibb Co's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BUE:BMY), the current Cyclically Adjusted FCF per Share is ARS2,857.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (BUE:BMY) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of ARS31,820.00 is trading 13.2% above its estimated GF Value™ of ARS28,117.77. GuruFocus considers Bristol-Myers Squibb Co to be Modestly Overvalued.

Key valuation signals for BUE:BMY:

  • Cyclically Adjusted FCF per Share: ARS2,857.89
  • GF Value™: ARS28,117.77 vs. price of ARS31,820.00 (13.2% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the BUE:BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
55GF Score

Get the complete analysis for BUE:BMY

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS31,820.00
Price
ARS28,117.77
GF Value